Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatry Advisor
The study authors concluded, “These findings further our understanding of shared and distinct neural mechanisms underlying mood disorders and assist in differential diagnosis, thereby guiding more accurate treatment strategies.”
Psychiatry March 18th 2026
The Canadian Journal of Psychiatry
“The prevalence of internalizing problems increased more rapidly among Canadians who used cannabis compared to those who do not.” — Study authors
Psych Congress Network
“TRD patients have extremely limited treatment options, and the unmet need remains profound.” — Guy Goodwin, MD, CMO, Compass Pathways
Psychiatry March 4th 2026
The American Journal of Nursing (AJN)
Patients seeking ketamine treatment have often spent years seeking to treat their mental health symptoms, and out of that desperation, seek out care without thoroughly vetting their options or practitioners.
Community/Public Health Nursing February 26th 2026
“Health care systems should recruit more trained psychologists and offer combinations of evidence-based pharmacotherapy and psychotherapy to patients with mood disorder, especially with suicide risk in resource-limited settings.” — Study authors, Journal of Psychiatric Research
Psychiatry February 18th 2026
Psychiatrist.com
Treatment preferences shifted to include nonaugmentative antidepressants and electroconvulsive therapy based on changes in patient characteristics.
Psychiatry February 4th 2026